Ascelia Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Ascelia Pharma has a total shareholder equity of SEK257.3M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK283.1M and SEK25.8M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 208.86m |
| Equity | SEK 257.32m |
| Total liabilities | SEK 25.77m |
| Total assets | SEK 283.09m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ACES's short term assets (SEK225.0M) exceed its short term liabilities (SEK25.6M).
Long Term Liabilities: ACES's short term assets (SEK225.0M) exceed its long term liabilities (SEK204.0K).
Debt to Equity History and Analysis
Debt Level: ACES is debt free.
Reducing Debt: ACES has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ACES has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ACES has less than a year of cash runway if free cash flow continues to reduce at historical rates of 44% each year